May 1st 2024
Throughout April, the FDA approved drugs for the treatment of diseases including solid tumors, lung cancer, multiple myeloma, bladder cancer, and low-grade glioma.
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!
View More
Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer
View More
8th Annual School of Nursing Oncology™
August 10, 2024
Register Now!
Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease
View More
Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
View More
Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?
View More
The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…
View More
Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care
View More
Flashy for a Cause: Raising Awareness for Childhood Cancers
September 20th 2016Chase After a Cure is running a Thunderclap campaign on Sept. 15 and is asking people to be flashy for a good cause: awareness and funds for childhood cancers. - See more at: http://www.curetoday.com/articles/flashy-for-a-cause-raising-awareness-for-childhood-cancers#sthash.uyBvOZyJ.dpuf
Sarcoma Awareness Spotlight: Why Younger Patients Need More Support
July 26th 2016Despite some advances in treatment options for patients with sarcomas, researchers are still actively seeking to improve outcomes for pediatric, adolescent and young adult patients, a group particularly impacted by this diagnosis.
Encouraging Childhood Cancer Survivors to Get Vaccinated Against HPV
July 13th 2016Although survivors of childhood cancer are at an increased risk of developing second cancers later in life, a recently reported study found that they are actually less likely to receive the vaccine series aimed at preventing the human papillomavirus (HPV) which is linked to a number of cancers.
Carlos Rodriguez-Galindo on Treating Rare Pediatric Cancer
July 11th 2016Carlos Rodriguez-Galindo, MD, chair of the Department of Global Pediatric Medicine and director of the International Outreach Program at St. Jude Children’s Research Hospital, and chair of the rare tumor committee at the Children’s Oncology Group, discusses treating rare pediatric cancers.
Intervention Eases Parental Caregiver Burden During Child's HSCT
April 27th 2016An intervention specifically aimed at reducing the trauma and anxiety that often comes with parenting a child undergoing hematopoietic stem cell transplant proved especially helpful for parents during the time of the actual transplant and subsequent hospitalization.
Abdominal Radiation May Increase Diabetes Risk in Childhood Cancer Survivors
January 20th 2016Previous studies have linked radiation to the pancreas during childhood to an increased risk of type 1 or 2 diabetes, and in a recent small study, researchers investigated the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers.
Better Treatment Options and Follow-Up Improve Outlook for Childhood Cancer Survivors
June 4th 2015Findings from an analysis of more than 34,000 participants in the Childhood Cancer Survivor Study show that among those who have survived at least 5 years, all-cause mortality at 15 years after diagnosis dropped by half from 12.4% to 6%.